Search - tctmd.com

Displaying 481 - 496 of 496

Sort: Relevancy | Date

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Daily News

Medical Therapy Alone Superior to Stenting for Intracranial Stenosis

September 07, 2011

News Daily News

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

L.A. McKeown

August 16, 2011

News Daily News

PFO-Stroke Link Takes Another Hit

Jason Kahn

August 11, 2011

News Daily News

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Caitlin E. Cox

August 10, 2011

News Daily News

Commentary Authors Urge Improvements to Device Approval Process

Caitlin E. Cox

July 20, 2011

News Daily News

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

June 24, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

Myocardial Injury Common with TAVI, But Clinical Import Less Certain

May 09, 2011

News Daily News

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

April 25, 2011

News Daily News

Early Morning Circadian Rhythms Linked to Stent Thrombosis

February 21, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

News Daily News

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Jason Kahn

February 09, 2011

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

News Daily News

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

Kim Dalton

September 03, 2009

Advertisement

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

Medical Therapy Alone Superior to Stenting for Intracranial Stenosis

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

PFO-Stroke Link Takes Another Hit

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Commentary Authors Urge Improvements to Device Approval Process

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Myocardial Injury Common with TAVI, But Clinical Import Less Certain

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

Early Morning Circadian Rhythms Linked to Stent Thrombosis

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content